Korea United Pharm (XKRX:033270) E10: ₩2,784.85 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:033270 Korea United Pharm Inc XKRX:033270
90 GF Score
Price ₩17,910.00
GF Value ₩20,354.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Korea United Pharm E10?

Korea United Pharm XKRX:033270 -1.38% 90 E10 is ₩2,784.85 as of Jun. 2026. GuruFocus rates XKRX:033270 with a GF Score™ of 90/100 and a GF Value™ of ₩20,354.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Korea United Pharm's adjusted earnings per share data for the three months ended in Jun. 2026 was ₩2,377.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩2,784.85 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Korea United Pharm's average E10 Growth Rate was 18.20% per year. During the past 3 years, the average E10 Growth Rate was 9.10% per year. During the past 5 years, the average E10 Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Korea United Pharm was 12.40% per year. The lowest was 5.80% per year. And the median was 9.10% per year.

As of today (2026-08-21), Korea United Pharm's current stock price is ₩17910.00. Korea United Pharm's E10 for the quarter that ended in Jun. 2026 was ₩2,784.85. Korea United Pharm's Shiller PE Ratio of today is 6.43.

During the past 13 years, the highest Shiller PE Ratio of Korea United Pharm was 63.10. The lowest was 6.20. And the median was 13.75.


Korea United Pharm  (XKRX:033270) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Korea United Pharm's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17910.00/2784.85
=6.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Korea United Pharm was 63.10. The lowest was 6.20. And the median was 13.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Korea United Pharm E10 Related Terms


Korea United Pharm E10 Historical Data

* Premium members only.

The historical data trend for Korea United Pharm's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korea United Pharm E10 Chart

Korea United Pharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,646.33 1,909.75 2,210.03 2,334.47 2,479.05

Korea United Pharm Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,376.23 2,445.02 2,479.05 2,535.80 2,784.85

XKRX:033270 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Korea United Pharm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korea United Pharm Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea United Pharm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Korea United Pharm's Shiller PE Ratio falls into.


XKRX:033270
90GF Score
Korea United Pharm Inc XKRX:033270
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Korea United Pharm E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Korea United Pharm's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2377/126.4904*126.4904
=2,377.000

Current CPI (Jun. 2026) = 126.4904.

Korea United Pharm Quarterly Data

per share eps CPI Adj_EPS
201609 286.000 101.461 356.553
201612 423.000 101.561 526.829
201703 331.000 102.851 407.079
201706 452.000 102.611 557.187
201709 721.000 103.491 881.236
201712 378.000 102.991 464.249
201803 575.000 104.101 698.669
201806 536.000 104.130 651.096
201809 492.000 105.651 589.049
201812 536.000 104.351 649.721
201903 627.000 104.491 759.008
201906 441.000 104.881 531.863
201909 606.000 105.200 728.640
201912 412.000 105.121 495.752
202003 787.000 105.354 944.888
202006 295.000 105.112 355.000
202009 533.000 106.198 634.848
202012 173.000 105.765 206.900
202103 615.000 107.357 724.605
202106 444.000 107.579 522.053
202109 727.000 108.759 845.524
202112 139.000 109.676 160.309
202203 767.000 111.848 867.411
202206 992.000 114.072 1,099.991
202209 1,597.000 114.715 1,760.926
202212 -314.000 115.179 -344.836
202303 977.000 116.507 1,060.715
202306 976.000 117.182 1,053.528
202309 1,145.000 118.964 1,217.444
202312 176.000 118.837 187.335
202403 1,308.000 120.123 1,377.331
202406 -434.000 120.007 -457.446
202409 356.000 120.861 372.581
202412 978.000 121.135 1,021.236
202503 860.000 122.590 887.362
202506 81.000 122.611 83.563
202509 923.000 123.402 946.102
202512 747.000 123.939 762.376
202603 876.000 125.236 884.774
202606 2,377.000 126.490 2,377.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₩2,784.85 mean?
Korea United Pharm (XKRX:033270) has a E10 of ₩2,784.85 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Korea United Pharm and its competitors.
Is Korea United Pharm's E10 too high?
Korea United Pharm's current E10 is ₩2,784.85. Overall, Korea United Pharm has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's E10 compare to ZTS?
Korea United Pharm's E10 of ₩2,784.85 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Korea United Pharm and its competitors. Korea United Pharm's current E10 is ₩2,784.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,354.74, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current E10 is ₩2,784.85. Korea United Pharm's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current E10 is ₩2,784.85 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Korea United Pharm (XKRX:033270) Overvalued in 2026?

Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued. The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,354.74. GuruFocus considers Korea United Pharm to be Modestly Undervalued.

Key valuation signals for XKRX:033270:

  • E10: ₩2,784.85
  • GF Value™: ₩20,354.74 vs. price of ₩17,910.00 (12% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Korea United Pharm Business Description

Address 404-10, Nojang-ri, Jeondong-myeon, Yeongi-gun, Chungnam, KOR, 339-840
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
90GF Score

Get the complete analysis for XKRX:033270

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩17,910.00
Price
₩20,354.74
GF Value